1329 related articles for article (PubMed ID: 16929250)
1. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
[TBL] [Abstract][Full Text] [Related]
2. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis.
Shen N; Lin H; Wu T; Wang D; Wang W; Xie H; Zhang J; Feng Z
Kidney Int; 2013 Jul; 84(1):64-77. PubMed ID: 23486519
[TBL] [Abstract][Full Text] [Related]
4. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.
Grygielko ET; Martin WM; Tweed C; Thornton P; Harling J; Brooks DP; Laping NJ
J Pharmacol Exp Ther; 2005 Jun; 313(3):943-51. PubMed ID: 15769863
[TBL] [Abstract][Full Text] [Related]
6. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
7. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
8. Specific molecular targeting of renal injury in obstructive nephropathy.
Chevalier RL
Kidney Int; 2006 Oct; 70(7):1200-1. PubMed ID: 16988728
[TBL] [Abstract][Full Text] [Related]
9. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
10. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ
Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438
[TBL] [Abstract][Full Text] [Related]
11. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors.
Yang YL; Liu YS; Chuang LY; Guh JY; Lee TC; Liao TN; Hung MY; Chiang TA
Endocrinology; 2009 Feb; 150(2):727-40. PubMed ID: 18832104
[TBL] [Abstract][Full Text] [Related]
13. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
14. A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.
Terashima H; Kato M; Yasumo H; Tsuchida H; Mizuno M; Sada T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F792-801. PubMed ID: 20660018
[TBL] [Abstract][Full Text] [Related]
15. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
Qi FH; Cai PP; Liu X; Si GM
Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
[TBL] [Abstract][Full Text] [Related]
17. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
18. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction.
Miyajima A; Chen J; Lawrence C; Ledbetter S; Soslow RA; Stern J; Jha S; Pigato J; Lemer ML; Poppas DP; Vaughan ED; Felsen D
Kidney Int; 2000 Dec; 58(6):2301-13. PubMed ID: 11115064
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
